Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Right place, right time, right peptide: DO keeps DM focused.

Lisa K Denzin1, Jennifer L Fallas, Maria Prendes

  • 1Sloan-Kettering Institute, Immunology Program, Memorial Sloan-Kettering Cancer Center, NY 10021, USA. denzinl@mskcc.org

Immunological Reviews
|September 27, 2005
PubMed
Summary

Human Leukocyte Antigen (HLA)-DM catalyzes peptide loading onto class II molecules. HLA-DO modulates this process, inhibiting fluid-phase antigen presentation but promoting B-cell receptor-mediated antigen presentation in B cells.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Delivery of DNA-encoded vaccines and proteins in mice using cutaneous suction-mediated transfection.

FEBS open bio·2026
Same author

Conformational variants of I-A<sup>k</sup> MHC class II molecules carry distinct immunopeptidomes.

Molecular immunology·2025
Same author

IFN-I promotes T-cell-independent immunity and RBC autoantibodies via modulation of B-1 cell subsets in murine SCD.

Blood·2024
Same author

Assessments of working group effectiveness in the planning of the New Jersey Kids Study: An applied mixed-methods study on the science of team science.

Journal of clinical and translational science·2024
Same author

The MHC Class II Antigen-Processing and Presentation Pathway Is Dysregulated in Type 1 Diabetes.

Journal of immunology (Baltimore, Md. : 1950)·2023
Same author

Intracellular DNA sensing by neutrophils and amplification of the innate immune response.

Frontiers in immunology·2023

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Major histocompatibility class II (MHC-II) molecules present peptides to T helper cells.
  • Human Leukocyte Antigen (HLA)-DM is a catalyst for MHC-II peptide loading in endosomal compartments.
  • HLA-DO (H-2O in mice) is a non-classical MHC class II molecule that modulates peptide loading.

Purpose of the Study:

  • To review the assembly, transport, and function of HLA-DO.
  • To emphasize the specific functions of HLA-DO/H-2O in antigen presentation.

Main Methods:

  • Literature review of studies on HLA-DO assembly, transport, and function.
  • Analysis of the impact of HLA-DO on antigen presentation pathways.

Main Results:

Related Experiment Videos

  • HLA-DM catalyzes peptide loading onto MHC-II molecules.
  • HLA-DO expression generally inhibits antigen presentation from fluid-phase endocytosis.
  • In B cells, HLA-DO specifically promotes antigen presentation from B-cell receptor internalization.

Conclusions:

  • HLA-DO plays a critical role in regulating antigen presentation by MHC-II molecules.
  • The function of HLA-DO is context-dependent, differing between general endocytosis and B-cell receptor-mediated pathways.